National medicine regulator, the Food and Drug Administration (FDA), recently approved the world's first vaccines to prevent RSV, or respiratory syncytial virus, for infants and elderly adults.
Sep 14, 2023
0
12
Canada on Tuesday approved an updated Moderna COVID vaccine targeting new variants, and is reviewing others likely to be rolled out this fall to mitigate infections once more on the rise.
Sep 12, 2023
0
2
This fall will see the circulation of three viruses—influenza, respiratory syncytial (RSV) and SARS-CoV-2, the virus that causes COVID.
Sep 11, 2023
0
58
Updated COVID-19 vaccines are coming soon, just in time to pair them with flu shots. And this fall, the first vaccines for another scary virus called RSV are rolling out to older adults and pregnant women.
Sep 9, 2023
0
11
Respiratory syncytial virus (RSV) is a common viral infection that affects people of all ages, with infants and older adults being particularly vulnerable to severe complications.
Sep 7, 2023
0
1
An increase in the Southeast of respiratory syncytial virus, better known as RSV, may be an early sign of the start of the respiratory virus season.
Sep 7, 2023
0
2
Ask Danielle Palmieri when her newborn son contracted RSV, and she doesn't give a season or even a month. She knows the exact day.
Sep 7, 2023
0
14
Doctors are seeing a spike in severe cases of respiratory syncytial virus (RSV) among young children in Florida and Georgia, U.S. health officials warned Tuesday.
Sep 6, 2023
0
9
Every year, respiratory syncytial viruses (RSV) cause countless respiratory infections worldwide. For infants, young children and people with preexisting conditions, the virus can be life-threatening.
Sep 4, 2023
0
1
As summer edges toward fall, thoughts turn to, well, vaccines.
Aug 30, 2023
0
29
